Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000241629 | SCV000307967 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV001697721 | SCV000528950 | benign | not provided | 2020-05-18 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000527971 | SCV000651088 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001697721 | SCV002497563 | likely benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | FLNC: BP4, BP7 |
Ambry Genetics | RCV002356345 | SCV002651734 | likely benign | Cardiovascular phenotype | 2019-04-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV003486790 | SCV004240662 | benign | Cardiomyopathy | 2023-05-16 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000241629 | SCV005040627 | benign | not specified | 2024-03-28 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000241629 | SCV001919614 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000241629 | SCV001927303 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000241629 | SCV001953863 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001697721 | SCV001968946 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001697721 | SCV002036530 | likely benign | not provided | no assertion criteria provided | clinical testing |